Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Aug 1;373(Pt 3):925–932. doi: 10.1042/BJ20030388

Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells.

Mark D Hasleton 1, J Claire Ibbitt 1, Helen C Hurst 1
PMCID: PMC1223543  PMID: 12733991

Abstract

The activator protein-2 (AP-2) family of DNA-binding transcription factors are developmentally regulated and also play a role in human neoplasia. In particular, the AP-2gamma protein has been shown to be overexpressed in a high percentage of breast tumours. In the present study, we report the complete sequence determination of the human TFAP2C gene encoding the AP-2gamma transcription factor plus the mapping of the transcription start site used in breast tumour-derived cells. The 5'-end of the gene lies within a CpG island and transcription is initiated at a single site within a classical initiator motif. We have gone on to investigate why some breast tumour-derived cell lines readily express AP-2gamma, whereas others do not, and show that the proximal promoter (+191 to -312) is differentially active in the two cell phenotypes. DNase footprinting led to the identification of three Sp1/Sp3-binding sites within this region, two of which are absolutely required both for promoter function and cell-type-specific activity. By Western blotting a panel of expressing and non-expressing breast tumour lines we show that the latter have higher levels of Sp3. Furthermore, increasing Sp3 levels in AP-2gamma-expressing cells led to the repression of AP-2gamma promoter activity, particularly when Sp3 inhibitory function was maximized through sumoylation. We propose that differences in the level and activity of Sp3 between breast tumour lines can determine the expression level of their AP-2gamma gene.

Full Text

The Full Text of this article is available as a PDF (247.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apt D., Watts R. M., Suske G., Bernard H. U. High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology. 1996 Oct 1;224(1):281–291. doi: 10.1006/viro.1996.0530. [DOI] [PubMed] [Google Scholar]
  2. Auman Heidi J., Nottoli Timothy, Lakiza Olga, Winger Quinton, Donaldson Stephanie, Williams Trevor. Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. Development. 2002 Jun;129(11):2733–2747. doi: 10.1242/dev.129.11.2733. [DOI] [PubMed] [Google Scholar]
  3. Bauer R., Imhof A., Pscherer A., Kopp H., Moser M., Seegers S., Kerscher M., Tainsky M. A., Hofstaedter F., Buettner R. The genomic structure of the human AP-2 transcription factor. Nucleic Acids Res. 1994 Apr 25;22(8):1413–1420. doi: 10.1093/nar/22.8.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bosher J. M., Totty N. F., Hsuan J. J., Williams T., Hurst H. C. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene. 1996 Oct 17;13(8):1701–1707. [PubMed] [Google Scholar]
  5. Bosher J. M., Williams T., Hurst H. C. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):744–747. doi: 10.1073/pnas.92.3.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Braun H., Koop R., Ertmer A., Nacht S., Suske G. Transcription factor Sp3 is regulated by acetylation. Nucleic Acids Res. 2001 Dec 15;29(24):4994–5000. doi: 10.1093/nar/29.24.4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brewer Stephanie, Jiang Xiaobing, Donaldson Stephanie, Williams Trevor, Sucov Henry M. Requirement for AP-2alpha in cardiac outflow tract morphogenesis. Mech Dev. 2002 Jan;110(1-2):139–149. doi: 10.1016/s0925-4773(01)00579-2. [DOI] [PubMed] [Google Scholar]
  8. Chazaud C., Oulad-Abdelghani M., Bouillet P., Décimo D., Chambon P., Dollé P. AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev. 1996 Jan;54(1):83–94. doi: 10.1016/0925-4773(95)00463-7. [DOI] [PubMed] [Google Scholar]
  9. Creaser P. C., D'Argenio D. A., Williams T. Comparative and functional analysis of the AP2 promoter indicates that conserved octamer and initiator elements are critical for activity. Nucleic Acids Res. 1996 Jul 1;24(13):2597–2605. doi: 10.1093/nar/24.13.2597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dennig J., Beato M., Suske G. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J. 1996 Oct 15;15(20):5659–5667. [PMC free article] [PubMed] [Google Scholar]
  11. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Discher D. J., Bishopric N. H., Wu X., Peterson C. A., Webster K. A. Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem. 1998 Oct 2;273(40):26087–26093. doi: 10.1074/jbc.273.40.26087. [DOI] [PubMed] [Google Scholar]
  13. Eloranta Jyrki J., Hurst Helen C. Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo. J Biol Chem. 2002 Jun 18;277(34):30798–30804. doi: 10.1074/jbc.M202780200. [DOI] [PubMed] [Google Scholar]
  14. Emami K. H., Burke T. W., Smale S. T. Sp1 activation of a TATA-less promoter requires a species-specific interaction involving transcription factor IID. Nucleic Acids Res. 1998 Feb 1;26(3):839–846. doi: 10.1093/nar/26.3.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fandos C., Sánchez-Feutrie M., Santalucía T., Viñals F., Cadefau J., Gumà A., Cussó R., Kaliman P., Canicio J., Palacín M. GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis. J Mol Biol. 1999 Nov 19;294(1):103–119. doi: 10.1006/jmbi.1999.3216. [DOI] [PubMed] [Google Scholar]
  16. Feng X., Teitelbaum S. L., Quiroz M. E., Cheng S. L., Lai C. F., Avioli L. V., Ross F. P. Sp1/Sp3 and PU.1 differentially regulate beta(5) integrin gene expression in macrophages and osteoblasts. J Biol Chem. 2000 Mar 24;275(12):8331–8340. doi: 10.1074/jbc.275.12.8331. [DOI] [PubMed] [Google Scholar]
  17. Gee J. M., Robertson J. F., Ellis I. O., Nicholson R. I., Hurst H. C. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol. 1999 Dec;189(4):514–520. doi: 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  18. Hagen G., Müller S., Beato M., Suske G. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 1994 Aug 15;13(16):3843–3851. doi: 10.1002/j.1460-2075.1994.tb06695.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Imhof A., Schuierer M., Werner O., Moser M., Roth C., Bauer R., Buettner R. Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor. Mol Cell Biol. 1999 Jan;19(1):194–204. doi: 10.1128/mcb.19.1.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S. T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol. 1994 Jan;14(1):116–127. doi: 10.1128/mcb.14.1.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kwon H. S., Kim M. S., Edenberg H. J., Hur M. W. Sp3 and Sp4 can repress transcription by competing with Sp1 for the core cis-elements on the human ADH5/FDH minimal promoter. J Biol Chem. 1999 Jan 1;274(1):20–28. doi: 10.1074/jbc.274.1.20. [DOI] [PubMed] [Google Scholar]
  22. Lo K., Smale S. T. Generality of a functional initiator consensus sequence. Gene. 1996 Dec 5;182(1-2):13–22. doi: 10.1016/s0378-1119(96)00438-6. [DOI] [PubMed] [Google Scholar]
  23. McPherson L. A., Baichwal V. R., Weigel R. J. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4342–4347. doi: 10.1073/pnas.94.9.4342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Moser M., Imhof A., Pscherer A., Bauer R., Amselgruber W., Sinowatz F., Hofstädter F., Schüle R., Buettner R. Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development. 1995 Sep;121(9):2779–2788. doi: 10.1242/dev.121.9.2779. [DOI] [PubMed] [Google Scholar]
  25. Moser M., Pscherer A., Roth C., Becker J., Mücher G., Zerres K., Dixkens C., Weis J., Guay-Woodford L., Buettner R. Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev. 1997 Aug 1;11(15):1938–1948. doi: 10.1101/gad.11.15.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Moser M., Rüschoff J., Buettner R. Comparative analysis of AP-2 alpha and AP-2 beta gene expression during murine embryogenesis. Dev Dyn. 1997 Jan;208(1):115–124. doi: 10.1002/(SICI)1097-0177(199701)208:1<115::AID-AJA11>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  27. Newman S. P., Bates N. P., Vernimmen D., Parker M. G., Hurst H. C. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene. 2000 Jan 27;19(4):490–497. doi: 10.1038/sj.onc.1203416. [DOI] [PubMed] [Google Scholar]
  28. Ross Sarah, Best Jennifer L., Zon Leonard I., Gill Grace. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol Cell. 2002 Oct;10(4):831–842. doi: 10.1016/s1097-2765(02)00682-2. [DOI] [PubMed] [Google Scholar]
  29. Sapetschnig Alexandra, Rischitor Grigore, Braun Harald, Doll Andreas, Schergaut Marion, Melchior Frauke, Suske Guntram. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 2002 Oct 1;21(19):5206–5215. doi: 10.1093/emboj/cdf510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Satoda M., Zhao F., Diaz G. A., Burn J., Goodship J., Davidson H. R., Pierpont M. E., Gelb B. D. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet. 2000 May;25(1):42–46. doi: 10.1038/75578. [DOI] [PubMed] [Google Scholar]
  31. Schorle H., Meier P., Buchert M., Jaenisch R., Mitchell P. J. Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature. 1996 May 16;381(6579):235–238. doi: 10.1038/381235a0. [DOI] [PubMed] [Google Scholar]
  32. Skinner A., Hurst H. C. Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. Oncogene. 1993 Dec;8(12):3393–3401. [PubMed] [Google Scholar]
  33. Suske G. The Sp-family of transcription factors. Gene. 1999 Oct 1;238(2):291–300. doi: 10.1016/s0378-1119(99)00357-1. [DOI] [PubMed] [Google Scholar]
  34. Turner B. C., Zhang J., Gumbs A. A., Maher M. G., Kaplan L., Carter D., Glazer P. M., Hurst H. C., Haffty B. G., Williams T. Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res. 1998 Dec 1;58(23):5466–5472. [PubMed] [Google Scholar]
  35. Werling Uwe, Schorle Hubert. Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol. 2002 May;22(9):3149–3156. doi: 10.1128/MCB.22.9.3149-3156.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Williams T., Admon A., Lüscher B., Tjian R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 1988 Dec;2(12A):1557–1569. doi: 10.1101/gad.2.12a.1557. [DOI] [PubMed] [Google Scholar]
  37. Williamson J. A., Bosher J. M., Skinner A., Sheer D., Williams T., Hurst H. C. Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors. Genomics. 1996 Jul 1;35(1):262–264. doi: 10.1006/geno.1996.0351. [DOI] [PubMed] [Google Scholar]
  38. Zeng Y. X., Somasundaram K., el-Deiry W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat Genet. 1997 Jan;15(1):78–82. doi: 10.1038/ng0197-78. [DOI] [PubMed] [Google Scholar]
  39. Zhang J., Hagopian-Donaldson S., Serbedzija G., Elsemore J., Plehn-Dujowich D., McMahon A. P., Flavell R. A., Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature. 1996 May 16;381(6579):238–241. doi: 10.1038/381238a0. [DOI] [PubMed] [Google Scholar]
  40. Zhao F., Satoda M., Licht J. D., Hayashizaki Y., Gelb B. D. Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem. 2001 Aug 24;276(44):40755–40760. doi: 10.1074/jbc.M106284200. [DOI] [PubMed] [Google Scholar]
  41. Zhu Chun-Hong, Domann Frederick E. Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth. Breast Cancer Res Treat. 2002 Jan;71(1):47–57. doi: 10.1023/a:1013378113916. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES